Doximity, Inc.

NYSE:DOCS

67.94 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 145.913138.288168.603136.832126.676118.057135.284113.612108.469110.966115.262102.18590.63993.65397.87679.3572.66966.68758.70945.11336.38836.35432.426
Cost of Revenue 15.79314.46714.18113.67613.5512.56712.1912.75913.15313.67713.52613.2113.07711.76511.0858.9517.9867.9937.8727.4567.8754.2813.78
Gross Profit 130.12123.821154.422123.156113.126105.49123.094100.85395.31697.289101.73688.97577.56281.88886.79170.39964.68358.69450.83737.65728.51332.07328.646
Gross Profit Ratio 0.8920.8950.9160.90.8930.8940.910.8880.8790.8770.8830.8710.8560.8740.8870.8870.890.880.8660.8350.7840.8820.883
Reseach & Development Expenses 26.79924.80322.42123.2422.57420.14819.94619.95821.93121.54120.51919.10419.02217.42416.22515.4613.24112.55811.4069.86610.0438.8918.605
General & Administrative Expenses 12.43912.72713.58510.1039.2559.9739.6418.9669.2479.7599.5138.7498.72410.6449.0798.8277.1965.7034.4783.2093.1021.7681.954
Selling & Marketing Expenses 36.36537.61138.49134.36735.24433.51734.95630.20134.45533.14833.2229.02128.13425.89925.69821.16119.37117.58617.01714.14513.28510.35210.669
SG&A 48.80450.33852.07644.4744.49943.4944.59739.16743.70242.90742.73337.7736.85836.54334.77729.98826.56723.28921.49517.35416.38712.1212.623
Other Expenses 0002.3040007.936000000000000000
Operating Expenses 75.60375.14174.49770.01467.07363.63864.54367.06165.63364.44863.25256.87455.8853.96751.00245.44839.80835.84732.90127.2226.4321.01121.265
Operating Income 54.51748.6879.92553.14246.05341.85258.55133.79229.68332.84138.48432.10121.68227.92135.78924.95124.87522.84717.93610.4372.08311.0627.418
Operating Income Ratio 0.3740.3520.4740.3880.3640.3550.4330.2970.2740.2960.3340.3140.2390.2980.3660.3140.3420.3430.3060.2310.0570.3040.229
Total Other Income Expenses Net 9.639.7149.9159.0297.1166.1014.4815.9034.8393.8752.4610.9080.804-0.0160.020.420.0450.0384.601-0.02-0.153-0.8860.325
Income Before Tax 64.14758.39489.8462.17153.16947.95363.03239.69534.52236.71640.94533.00922.48627.90535.80925.37124.9222.88522.53710.4171.9310.1767.743
Income Before Tax Ratio 0.440.4220.5330.4540.420.4060.4660.3490.3180.3310.3550.3230.2480.2980.3660.320.3430.3430.3840.2310.0530.280.239
Income Tax Expense 10.827-4.06414.64418.01711.7927.33515.0769.0936.1166.0487.4776.710.103-8.821-19.838-10.717-1.4021.4025.3060.380.4712.7071.84
Net Income 53.3262.45875.19644.15441.37740.61847.95630.60228.40630.66833.46826.29922.38336.72655.64736.08826.32221.48317.23110.0371.4593.5145.903
Net Income Ratio 0.3650.4520.4460.3230.3270.3440.3540.2690.2620.2760.290.2570.2470.3920.5690.4550.3620.3220.2930.2220.040.0970.182
EPS 0.280.330.40.240.220.220.260.160.150.160.170.140.120.170.290.190.0580.0590.0290.00900.0190.033
EPS Diluted 0.270.310.370.220.210.20.240.150.130.140.160.120.10.170.260.170.0580.0590.0290.00900.0190.033
EBITDA 66.94151.50982.5858.05948.61544.461.0644.33232.28735.54941.134.6924.05229.28937.1526.10926.02823.83818.95111.3652.85110.9767.937
EBITDA Ratio 0.4590.3720.490.4240.3840.3760.4510.390.2980.320.3570.3390.2650.3130.380.3290.3580.3570.3230.2520.0780.3020.245